Leukotriene D4 and Interleukin-13 Cooperate to Increase the Release of Eotaxin-3 by Airway Epithelial Cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Provost, Véronique ^a   Langlois, Anick ^a   Chouinard, François ^a   Rola Pleszczynski, Marek ^b   Chakir, Jamila ^a   Flamand, Nicolas ^a   Laviolette, Michel ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; PEPTIDOLEUKOTRIENE 1; PEPTIDOLEUKOTRIENE RECEPTOR; UNCLASSIFIED DRUG; BETA CHEMOKINE; CCL24 PROTEIN, HUMAN; CCL26 PROTEIN, HUMAN; CYSTEINE; CYSTEINYL-LEUKOTRIENE; LEUKOTRIENE; RECOMBINANT PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; ASTHMA; BIOLOGICAL MODEL; BIOSYNTHESIS; BRONCHUS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INFLAMMATION; KINETICS; METABOLISM; METHODOLOGY; TH2 CELL;

ASTHMA; BRONCHI; CHEMOKINE CCL24; CHEMOKINES, CC; CYSTEINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; KINETICS; LEUKOTRIENE D4; LEUKOTRIENES; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; TH2 CELLS;

EID: 84865631568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043544     Document Type: Article

References (57)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM, (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161: 1720-1745.
2. Komiya A, Nagase H, Yamada H, Sekiya T, Yamaguchi M, et al. (2003) Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell Immunol 225: 91-100.
3. Ferland C, Guilbert M, Davoine F, Flamand N, Chakir J, et al. (2001) Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. J Leukoc Biol 69: 772-778.
4. Pease JE, Williams TJ, (2001) Eotaxin and asthma. Curr Opin Pharmacol 1: 248-253.
5. Banwell ME, Tolley NS, Williams TJ, Mitchell TJ, (2002) Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids. Cytokine 17: 317-323.
6. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, et al. (1997) Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 27: 3507-3516.
7. Hoeck J, Woisetschlager M, (2001) Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 167: 3216-3222.
8. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, et al. (1999) Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 163: 6876-6883.
9. Guilbert M, Ferland C, Bosse M, Flamand N, Lavigne S, et al. (1999) 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. Am J Respir Cell Mol Biol 21: 97-104.
10. Nicosia S, Capra V, Rovati GE, (2001) Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 14: 3-19.
11. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, et al. (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275: 30531-30536.
12. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399: 789-793.
13. Figueroa DJ, Breyer RM, Defoe SK, Kargman S, Daugherty BL, et al. (2001) Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 163: 226-233.
14. Bosse Y, Thompson C, Audette K, Stankova J, Rola-Pleszczynski M, (2008) Interleukin-4 and interleukin-13 enhance human bronchial smooth muscle cell proliferation. Int Arch Allergy Immunol 146: 138-148.
15. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M, (2003) CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 111: 1032-1040.
16. Thivierge M, Stankova J, Rola-Pleszczynski M, (2001) IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167: 2855-2860.
17. Zhu J, Qiu YS, Figueroa DJ, Bandi V, Galczenski H, et al. (2005) Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 33: 531-540.
18. Flamand N, Mancuso P, Serezani CH, Brock TG, (2007) Leukotrienes: mediators that have been typecast as villains. Cell Mol Life Sci 64: 2657-2670.
19. Arcoleo F, Milano S, D'Agostino P, Cillari E, (1995) Effect of exogenous leukotriene B4 (LTB4) on BALB/c mice splenocyte production of Th1 and Th2 lymphokines. Int J Immunopharmacol 17: 457-463.
20. Stankova J, Dupuis G, Gagnon N, Thivierge M, Turcotte S, et al. (1993) Priming of human monocytes with leukotriene B4 enhances their sensitivity in IL-2-driven tumor necrosis factor-alpha production. Transcriptional and post-transcriptional up-regulation of IL-2 receptors. J Immunol 150: 4041-4051.
21. Yamaoka KA, Kolb JP, (1993) Leukotriene B4 induces interleukin 5 generation from human T lymphocytes. Eur J Immunol 23: 2392-2398.
22. Lee KS, Kim SR, Park HS, Park SJ, Min KH, et al. (2007) Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice. J Allergy Clin Immunol 119: 141-149.
23. Mellor EA, Austen KF, Boyce JA, (2002) Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195: 583-592.
24. Menard G, Bissonnette EY, (2000) Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation. Am J Respir Cell Mol Biol 23: 572-577.
25. Wong GW, Foster PS, Yasuda S, Qi JC, Mahalingam S, et al. (2002) Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway. J Biol Chem 277: 41906-41915.
26. Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, et al. (2003) Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 112: 369-374.
27. Perng DW, Wu YC, Chang KT, Wu MT, Chiou YC, et al. (2006) Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 34: 101-107.
28. Milano S, Arcoleo F, Dieli M, D'Agostino R, De NG, et al. (1996) Ex vivo evidence for PGE2 and LTB4 involvement in cutaneous leishmaniasis: relation with infection status and cytokine production. Parasitology 112 (Pt 1): 13-19.
29. Mita H, Hasegawa M, Saito H, Akiyama K, (2001) Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. Clin Exp Allergy 31: 1714-1723.
30. Rola-Pleszczynski M, Stankova J, (2007) Cytokine-leukotriene receptor interactions. ScientificWorldJournal 7: 1348-1358.
31. Chatila TA, (2004) Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10: 493-499.
32. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, et al. (2001) Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 24: 755-761.
33. Abonyo BO, Lebby KD, Tonry JH, Ahmad M, Heiman AS, (2006) Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells. Cytokine 36: 237-244.
34. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M, (1997) Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun 236: 299-301.
35. Berkman N, Ohnona S, Chung FK, Breuer R, (2001) Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24: 682-687.
36. Ravensberg AJ, Ricciardolo FL, van Schadewijk A, Rabe KF, Sterk PJ, et al. (2005) Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 115: 779-785.
37. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B, (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288: 484-486.
38. Suzuki S, Takeuchi K, Ishinaga H, Basbaum C, Majima Y, (2008) Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells. Pharmacology 81: 221-228.
39. Bosse Y, Thompson C, McMahon S, Dubois CM, Stankova J, et al. (2008) Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy 38: 113-121.
40. Asakura T, Ishii Y, Chibana K, Fukuda T, (2004) Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta. J Allergy Clin Immunol 114: 310-315.
41. Woszczek G, Pawliczak R, Qi HY, Nagineni S, Alsaaty S, et al. (2005) Functional characterization of human cysteinyl leukotriene 1 receptor gene structure. J Immunol 175: 5152-5159.
42. Chibana K, Ishii Y, Asakura T, Fukuda T, (2003) Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 170: 4290-4295.
43. Kagami S, Saeki H, Komine M, Kakinuma T, Tsunemi Y, et al. (2005) Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells. Clin Exp Immunol 141: 459-466.
44. Blanchard C, Durual S, Estienne M, Emami S, Vasseur S, et al. (2005) Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int J Biochem Cell Biol 37: 2559-2573.
45. Zhou L, Kawate T, Liu X, Kim YB, Zhao Y, et al. (2012) STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells. Bioorg Med Chem 20: 750-758.
46. Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J, (2005) SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol 42: 295-303.
47. Serezani CH, Lewis C, Jancar S, Peters-Golden M, (2011) Leukotriene B4 amplifies NF-kappaB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. J Clin Invest 121: 671-682.
48. Early SB, Barekzi E, Negri J, Hise K, Borish L, et al. (2007) Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells. Am J Respir Cell Mol Biol 36: 715-720.
49. Saito M, Murata T, Watanabe K, Kawakami K, Suzuki M, et al. (2005) Adenoviral vector-mediated gene transfer of IL-13Ralpha2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers. Int J Cancer 116: 1-8.
50. Akaiwa M, Yu B, Umeshita-Suyama R, Terada N, Suto H, et al. (2001) Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 13: 75-84.
51. Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, et al. (2002) Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 169: 407-414.
52. Yasunaga S, Yuyama N, Arima K, Tanaka H, Toda S, et al. (2003) The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells. Cytokine 24: 293-303.
53. Oh CK, Geba GP, Molfino N, (2010) Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19: 46-54.
54. Bandeira-Melo C, Herbst A, Weller PF, (2001) Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 24: 653-657.
55. Chakir J, Page N, Hamid Q, Laviolette M, Boulet LP, et al. (2001) Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma. J Allergy Clin Immunol 107: 36-40.
56. Langlois A, Ferland C, Tremblay GM, Laviolette M, (2006) Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. J Allergy Clin Immunol 118: 113-119.
57. Chouinard F, Lefebvre JS, Navarro P, Bouchard L, Ferland C, et al. (2011) The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene B4 biosynthesis. J Immunol 186: 3188-3196.